Redhill Biopharma Ltd.-SP ADRRDHL

13F holders, Q1 2026 (March 31)
16holders −1
3new positions
4sold out
1famous investor
$0.75avg. 13F price*

At the end of Q1 2026, 16 institutions reported holding Redhill Biopharma Ltd.-SP ADR (RDHL) in their 13F filings, down 1 from Q4 2025. 3 opened new positions and 4 sold out. The largest holders were Yorkville Advisors Global, LP ($261K), Gagnon Securities LLC ($66K) and Citadel Advisors ($15K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Redhill Biopharma Ltd.-SP ADR
CUSIP
757468301
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q3 2024: 10Q3 2024Q4 2024: 11Q4 2024Q1 2025: 12Q1 2025Q2 2025: 12Q2 2025Q3 2025: 14Q3 2025Q4 2025: 17Q4 2025Q1 2026: 16Q1 2026Q2 2026: 14Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions3$32K
Exits4$370

All 13F filers, Q4 2025 → Q1 2026: 55,264 shares bought and 36,083 shares sold, net +19,181 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 16 holders

Yorkville Advisors Global, LP 0.18% Reduce -9.2% 350,870 $261K
Gagnon Securities LLC 0.02% Add +2.7% 88,405 $66K
Citadel Advisors 0.00% Add +33.6% 20,673 $15K
XTX Topco Ltd 0.00% New 15,163 $11K
StoneX Group Inc. 0.00% New 14,481 $11K
Two Sigma Securities, LLC 0.00% New 13,019 $10K
GAMMA Investing LLC 0.00% Add +38.4% 6,684 $5K
Rhumbline Advisers 0.00% Add +91.0% 5,116 $4K
Federation des caisses Desjardins du Quebec 0.00% No change 3,388 $3K
UBS Group AG 0.00% Add +4488.9% 826 $615
Your Advocates Ltd., LLP 0.00% No change 19 $14
Smartleaf Asset Management LLC 0.00% No change 5 $4
SBI Securities Co., Ltd. 0.00% No change 4 $3
Morgan Stanley 0.00% No change 1 $1
Vermillion Wealth Management, Inc. 0.00% No change 2 $1
Royal Bank of Canada 0.00% No change 1 $0

"% of holder's portfolio" is RDHL's weight in each manager's 13F, not the share of Redhill Biopharma Ltd.-SP ADR the manager owns.